Optimizing the Management Algorithm for Heartburn in General Gastroenterology: Cost-Effectiveness and Cost-Minimization Analysis

This publication has 37 references indexed in Scilit:

• The Ethics Of ‘Fail First’: Guidelines And Practical Scenarios For Step Therapy Coverage Policies
  Health Affairs, 2014
• PPI therapy is equally effective in well‐defined non‐erosive reflux disease and in reflux esophagitis: a meta‐analysis
  Neurogastroenterology & Motility, 2012
• Estimating the Relationship between Preference-Based Generic Utility Instruments and Disease-Specific Quality-of-Life Measures in Severe Chronic Constipation
  PharmacoEconomics, 2011
• Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study
  Gut, 2010
• Gastro-oesophageal reflux symptoms, oesophagitis and Barrett’s oesophagus in the general population: the Loiano–Monghidoro study
  Gut, 2008
• Relationship between symptom load of gastro‐oesophageal reflux disease and health‐related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort
  Alimentary Pharmacology & Therapeutics, 2008
• Cost of gastro‐oesophageal reflux disease to the employer: a perspective from the United States
  Alimentary Pharmacology & Therapeutics, 2007
• Patient-Derived Health State Utilities for Gastroesophageal Reflux Disease
  American Journal of Gastroenterology, 2005
• High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: A Kalixanda study report
  Scandinavian Journal of Gastroenterology, 2005
• The burden of illness of gastro‐oesophageal reflux disease: impact on work productivity
  Alimentary Pharmacology & Therapeutics, 2003